Bio2 Technologies (Woburn, Mass.) has raised about $4.3 million as it continues with a clinical trial of its Vitrium resorbable orthopedic biomaterial for musculoskeletal surgery. Bio2 had sought to raise $6.5 million in the funding round, according to a Form D filed Sept. 6 with the U.S. Securities and Exchange Commission. Made of bioactive glass, […]
The Massachusetts Life Sciences Center awarded a total of nearly $4 million in loans to 4 Boston-area life sciences startups – Arch Therapeutics, Bio2 Technologies, ImmuneXcite and MedicaMetrix each received loans of up to $1 million.
The quasi-public agency’s flagship investment program supports and "de-risks" early-stage companies by providing loans to match other sources of capital as a part of Massachusetts’ 10 year, $1 billion Life Sciences Initiative.
Bio2 Technologies Inc. raised $1.1 million in an equity offering, according to a regulatory filing.
The Woburn, Mass.-based orthopedic bio-scaffold developer opened the sale June 28, making $2 million in equity available in minimum purchases of $20,000. Eighteen investors had ponied up for the offering as of the July 1 filing.